Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
super omega-3
- Development stage
- Unknown
- Lead developer
- 3T Federal Solutions
- Modality
- Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Super Omega-3 is a dietary supplement containing a combination of omega-3 fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), derived from fish oil. These essential fatty acids are well-studied for their roles in supporting cardiovascular health, cognitive function, vision, and anti-inflammatory processes. EPA is known for its anti-inflammatory effects, while DHA serves as a structural component in brain and eye tissues. The mechanism of action involves incorporation into cell membranes where they modulate membrane fluidity and serve as precursors to bioactive lipid mediators that regulate inflammation and other physiological processes[1][2][6]. Some formulations may also include additional components such as olive extract or sesame lignans to enhance antioxidant properties[3].
- Brand names
- Super Omega-3Super Omega 3
- Other names
- fish oil concentratepolyunsaturated fatty acidsPUFAeicosapentaenoic aciddocosahexaenoic acidEPADHA
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on super omega-3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on super omega-3.